Suji Jeong
Stock Analyst at Jefferies
(1.28)
# 3,132
Out of 4,479 analysts
5
Total ratings
50%
Success rate
7.64%
Average return
Main Sectors:
Top Industries:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SVRA Savara | Downgrades: Hold | $2 | $4.30 | -53.49% | 1 | Apr 3, 2023 | |
| INZY Inozyme Pharma | Upgrades: Buy | $4.5 → $6 | $4.42 | +35.75% | 2 | Mar 23, 2023 | |
| ANNX Annexon | Initiates: Buy | $12 | $4.57 | +162.87% | 1 | Sep 16, 2022 | |
| STOK Stoke Therapeutics | Initiates: Buy | $50 | $12.83 | +289.71% | 1 | Jan 31, 2022 |
Savara
Apr 3, 2023
Downgrades: Hold
Price Target: $2
Current: $4.30
Upside: -53.49%
Inozyme Pharma
Mar 23, 2023
Upgrades: Buy
Price Target: $4.5 → $6
Current: $4.42
Upside: +35.75%
Annexon
Sep 16, 2022
Initiates: Buy
Price Target: $12
Current: $4.57
Upside: +162.87%
Stoke Therapeutics
Jan 31, 2022
Initiates: Buy
Price Target: $50
Current: $12.83
Upside: +289.71%